SYSTEMS AND METHODS FOR RELEASING NANOSPHERE PARTICLES WITHIN A CATHETER PUMP ASSEMBLY AND REDUCING A FLUID PRESSURE THEREOF
20230115631 · 2023-04-13
Inventors
Cpc classification
A61M60/237
HUMAN NECESSITIES
B82Y30/00
PERFORMING OPERATIONS; TRANSPORTING
A61M60/13
HUMAN NECESSITIES
A61M60/216
HUMAN NECESSITIES
A61M60/414
HUMAN NECESSITIES
International classification
A61M60/13
HUMAN NECESSITIES
A61M60/216
HUMAN NECESSITIES
A61M60/414
HUMAN NECESSITIES
Abstract
A catheter pump system includes a shaft assembly, an impeller coupled to a distal portion of the shaft assembly, and a motor assembly coupled to a proximal portion of the shaft assembly. The motor assembly is configured to drive the impeller via the shaft assembly. The catheter pump system also includes at least one valve operable to release one of i) a clearing fluid or ii) nanosphere particles into the catheter pump system, such as for example, in response to a fluid pressure within the catheter pump system exceeding a threshold fluid pressure, and/or in response to another internal condition of the catheter pump system.
Claims
1. A catheter pump system comprising: a shaft assembly; an impeller coupled to a distal portion of the shaft assembly; a motor assembly coupled to a proximal portion of the shaft assembly, the motor assembly configured to drive the impeller via the shaft assembly; and a nanosphere lubrication injection applicator (“NLIA”) fluidly coupled to at least one of the shaft assembly or the motor assembly, the NLIA configured to supply nanosphere particles to at least one of the shaft assembly or the motor assembly.
2. The catheter pump system of claim 1, wherein the NLIA includes, at least, a nanosphere particle reservoir, the nanosphere particle reservoir containing the nanosphere particles prior to the nanosphere particles being supplied to the at least one of the shaft assembly or the motor assembly.
3. The catheter pump system of claim 1, wherein the nanosphere particles have a diameter in the range of 5 nanometers to 100 nanometers.
4. The catheter pump system of claim 1, wherein the nanosphere particles include at least one of thrombogenic properties, anticoagulation properties, anti-foaming properties, or hydrophilic properties.
5. The catheter pump system of claim 1, wherein the nanosphere particles include at least one lubricant.
6. The catheter pump system of claim 1, wherein the nanosphere particles include at least one lubricant derived from at least one of a mineral oil, a synthetic hydrocarbon.
7. The catheter pump system of claim 1, wherein the nanosphere particles include at least one of copper (Cu), copper oxide (CuO), Iron (Fe), Nickel (Ni), Titanium Dioxide (TiO.sub.2).
8. The catheter pump system of claim 1, further comprising: at least one sensor configured to detect a fluid pressure within the catheter pump system; and at least one valve configured to be controlled to release nanosphere particles from the NLIA into the catheter pump system in response to the fluid pressure being greater than a threshold fluid pressure.
9. A catheter pump system comprising: a shaft assembly; an impeller coupled to a distal portion of the shaft assembly; a motor assembly coupled to a proximal portion of the shaft assembly, the motor assembly configured to drive the impeller via the shaft assembly; and at least one valve operable to release one of i) a clearing fluid or ii) nanosphere particles into the catheter pump system in response to a fluid pressure within the catheter pump system exceeding a threshold fluid pressure.
10. The catheter pump system of claim 9, further comprising: at least one sensor configured to detect the fluid pressure within the catheter pump system.
11. The catheter pump system of claim 9, further comprising: a nanosphere lubrication injection applicator (“NLIA”) fluidly coupled to the catheter pump system.
12. The catheter pump system of claim 11, wherein the NLIA is configured to supply nanosphere particles to the catheter pump system.
13. The catheter pump system of claim 11, wherein the NLIA includes, at least, a nanosphere particle reservoir, the nanosphere particle reservoir housing the nanosphere particles.
14. The catheter pump system of claim 9, wherein the nanosphere particles have a diameter in the range of 5 nanometers to 100 nanometers.
15. The catheter pump system of claim 9, wherein the nanosphere particles include at least one of thrombogenic properties, anticoagulation properties, anti-foaming properties, or hydrophilic properties.
16. The catheter pump system of claim 9, wherein the nanosphere particles include at least one lubricant.
17. The catheter pump system of claim 9, wherein the nanosphere particles include at least one lubricant derived from at least one of a mineral oil, a synthetic hydrocarbon.
18. The catheter pump system of claim 9, further comprising: at least one layer of nanosphere particles coated on at least a portion of one of the shaft assembly, the impeller, and the motor assembly.
19. The catheter pump system of claim 9, wherein the shaft assembly defines at least one lumen, and wherein the at least one lumen includes a smooth interior surface configured to reduce turbulence and facilitate fluid flow therethrough.
20. A method for operating a catheter pump system, the method comprising: providing the catheter pump system, the catheter pump system including: a shaft assembly; an impeller coupled to a distal portion of the shaft assembly; a motor assembly coupled to a proximal portion of the shaft assembly, the motor assembly configured to drive the impeller via the shaft assembly; and at least one valve operable to release one of i) a clearing fluid or ii) nanosphere particles into the catheter pump system; detecting a fluid pressure within the catheter pump assembly; and in response to detecting the fluid pressure, releasing one of i) the clearing fluid or ii) the nanosphere particles into the catheter pump system to facilitate reducing the fluid pressure within the catheter pump assembly.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0015] A more complete appreciation of the subject matter of this application and the various advantages thereof can be realized by reference to the following detailed description, in which reference is made to the accompanying drawings in which:
[0016]
[0017]
[0018]
[0019]
[0020]
[0021]
[0022]
[0023]
[0024]
[0025]
[0026]
[0027]
[0028]
[0029]
[0030]
[0031]
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041] More detailed descriptions of various embodiments of components for heart pumps useful to treat patients experiencing cardiac stress, including acute heart failure, are set forth below.
DETAILED DESCRIPTION
[0042] This application is generally directed to apparatuses for inducing motion of a fluid relative to the apparatus. Examples of circulatory support systems for treating heart failure, and in particular emergent and/or acute heart failure, are disclosed in U.S. Pat. Nos. 4,625,712; 4,686,982; 4,747,406; 4,895,557; 4,944,722; 6,176,848; 6,926,662; 7,022,100; 7,393,181; 7,841,976; 8,157,719; 8,489,190; 8,597,170; 8,721,517 and U.S. Pub. Nos. 2012/0178986 and 2014/0010686, the entire contents of which patents and publications are incorporated by reference for all purposes. In addition, this application incorporates by reference in its entirety and for all purposes the subject matter disclosed in each of the following applications and the provisional applications to which they claim priority: application Ser. No. 15/003,576, entitled “REDUCED ROTATIONAL MASS MOTOR ASSEMBLY FOR CATHETER PUMP,” filed on Jan. 21, 2016, and claiming priority to U.S. Provisional Patent Application No. 62/106,670; application Ser. No. 15/003,682, entitled “MOTOR ASSEMBLY WITH HEAT EXCHANGER FOR CATHETER PUMP,” filed on Jan. 21, 2016, and claiming priority to U.S. Provisional Patent Application No. 62/106,675; and application Ser. No. 15/003,696, entitled “ATTACHMENT MECHANISMS FOR MOTOR OF CATHETER PUMP,” filed on Jan. 21, 2016, and claiming priority to U.S. Provisional Patent Application No. 62/106,673.
[0043] In one example, an impeller can be coupled at a distal portion of the apparatus. In some embodiments, the motor is a brushless DC (BLDC) motor. In some embodiments, the motor is a micro BLDC motor. Some embodiments generally relate to various configurations for a motor assembly adapted to drive an impeller at a distal end of a catheter pump, e.g., a percutaneous heart pump. The motor described herein may be used for other applications including catheter-based devices like an atherectomy device. In such applications, the disclosed motor assembly is disposed outside the patient in some embodiments. In other embodiments, the disclosed motor assembly and/or features of the motor are miniaturized and sized to be inserted within the body, e.g., within the vasculature.
[0044]
[0045] The pump 100A includes a catheter assembly 101 that can be coupled with the motor assembly 1 and can house an impeller in an impeller assembly 116A within a distal portion of the catheter assembly 101 of the pump 100A. In various embodiments, the impeller is rotated remotely by the motor 1 when the pump 100A is operating. For example, the motor 1 can be disposed outside the patient. In some embodiments, the motor 1 is separate from the console 122, e.g., to be placed closer to the patient. In the exemplary system the pump is placed in the patient in a sterile environment and the console is outside the sterile environment. In one embodiment, the motor is disposed on the sterile side of the system. In other embodiments, the motor 1 is part of the console 122.
[0046] In still other embodiments, the motor 1 is miniaturized to be insertable into the patient. For example,
[0047]
[0048] The impeller assembly 116A (e.g., the impeller and cannula) can be expandable and collapsible. In the collapsed state, the distal end of the catheter pump 100A can be advanced to the heart, for example, through an artery. In the expanded state the impeller assembly 116A is able to pump blood at relatively high flow rates. In particular, the expandable cannula and impeller configuration allows for decoupling of the insertion size and flow rate, in other words, it allows for higher flow rates than would be possible through a lumen limited to the insertion size with all other things being equal. In
[0049] The mechanical components rotatably supporting the impeller within the impeller assembly 116A permit relatively high rotational speeds while controlling heat and particle generation that can come with high speeds. The infusion system delivers a cooling and lubricating solution to the distal portion of the catheter pump 100A for these purposes. The space for delivery of this fluid is extremely limited. Some of the space is also used for return of the fluid as waste fluid. Providing secure connection and reliable routing of fluid into and out of the catheter pump 100A is critical and challenging in view of the small profile of the catheter assembly 101.
[0050] When activated, the catheter pump 100A can effectively support, restore and/or increase the flow of blood out of the heart and through the patient's vascular system. In various embodiments disclosed herein, the pump 100A can be configured to produce a maximum flow rate (e.g. zero mm Hg backpressure) of greater than 4 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, greater than 6 Lpm, greater than 6.5 Lpm, greater than 7 Lpm, greater than 7.5 Lpm, greater than 8 Lpm, greater than 9 Lpm, or greater than 10 Lpm. In various embodiments, the pump 100A can be configured to produce an average flow rate at 62 mmHg of greater than 2 Lpm, greater than 2.5 Lpm, greater than 3 Lpm, greater than 3.5 Lpm, greater than 4 Lpm, greater than 4.25 Lpm, greater than 4.5 Lpm, greater than 5 Lpm, greater than 5.5 Lpm, greater than 6 Lpm, greater than 6.5 Lpm, greater than 7 Lpm, greater than 8 Lpm, or greater than 9 Lpm.
[0051] Various aspects of the pump and associated components can be combined with or substituted for those disclosed in U.S. Pat. Nos. 7,393,181; 8,376,707; 7,841,976; 7,022,100; and 7,998,054, and in U.S. Pub. Nos. 2011/0004046; 2012/0178986; 2012/0172655; 2012/0178985; and 2012/0004495, the entire contents of each of which are incorporated herein for all purposes by reference. In addition, various aspects of the pump and system can be combined with those disclosed in U.S. Patent Publication No. US 2013/0303970, entitled “DISTAL BEARING SUPPORT,” filed on Mar. 13, 2013; U.S. Patent Publication No. US 2014/0275725, entitled “FLUID HANDLING SYSTEM,” filed on Mar. 11, 2014; U.S. Patent Publication No. US 2013/0303969, entitled “SHEATH SYSTEM FOR CATHETER PUMP,” filed on Mar. 13, 2013; U.S. Patent Publication No. US 2013/0303830, entitled “IMPELLER FOR CATHETER PUMP,” filed on Mar. 13, 2013; U.S. Patent Publication No. US 2014/0012065, entitled “CATHETER PUMP,” filed on Mar. 13, 2013; and U.S. Patent Publication No. US 2014/0010686, entitled “MOTOR ASSEMBLY FOR CATHETER PUMP,” filed on Mar. 13, 2013, the entire contents of each of which are incorporated herein for all purposes by reference.
[0052] Moving from a distal end 1450 of the catheter assembly 101 of the catheter pump 100A of
[0053] In various embodiments, the pump is configured to be primed with fluid. Turning to
[0054] The priming operation can proceed by introducing fluid into the sealed priming apparatus 1400 to expel air from the impeller assembly 116A and the elongate body 174A. Fluid can be introduced into the priming apparatus 1400 in a variety of ways. For example, fluid can be introduced distally through the elongate body 174A into the priming apparatus 1400. In other embodiments, an inlet, such as a luer, can optionally be formed on a side of the primer housing 1401 to allow for introduction of fluid into the priming apparatus 1400. A gas permeable membrane can be disposed on a distal end 1404 of the primer housing 1401. The gas permeable membrane can permit air to escape from the primer housing 1401 during priming.
[0055] The priming apparatus 1400 also can advantageously be configured to collapse an expandable portion of the catheter pump 100A. The primer housing 1401 can include a funnel 1415 where the inner diameter of the housing decreases from distal to proximal. The funnel may be gently curved such that relative proximal movement of the impeller housing causes the impeller housing to be collapsed by the funnel 1415. During or after the impeller housing has been fully collapsed, the distal end 170A of the elongate body 174A can be moved distally relative to the collapsed housing. After the impeller housing is fully collapsed and retracted into the elongate body 174A of the sheath assembly, the catheter pump 100A can be removed from the priming apparatus 1400 before a percutaneous heart procedure is performed, e.g., before the pump 100A is activated to pump blood. The embodiments disclosed herein may be implemented such that the total time for infusing the system is minimized or reduced. For example, in some implementations, the time to fully infuse the system can be about six minutes or less. In other implementations, the time to infuse can be about three minutes or less. In yet other implementations, the total time to infuse the system can be about 45 seconds or less. It should be appreciated that lower times to infuse can be advantageous for use with cardiovascular patients. Although the described pump is primed with fluid, one will appreciate from the description herein that the priming may be optional. For example, the pump can be prepared such that all air is removed before it is packaged. In another example, air is removed by placing the pump under vacuum.
[0056] With continued reference to
[0057] Further, as shown in
[0058] Fluid (e.g., saline) can be provided from outside the patient (e.g., by way of one or more supply bags) to the pump through a supply lumen in the catheter body. The fluid can return to the motor assembly 1 by way of a lumen (e.g., a central or interior lumen) of the catheter body. For example, as explained herein, the fluid can return to the motor assembly 1 through the same lumen in which the drive shaft is disposed. In addition, a waste line 7 can extend from the motor assembly 1 to a waste reservoir 126. Waste fluid from the catheter pump 100A can pass through the motor assembly 1 and out to the reservoir 126 by way of the waste line 7. In various embodiments, the waste fluid flows to the motor assembly 1 and the reservoir 126 at a flow rate which is lower than that at which the fluid is supplied to the patient. For example, some of the supplied fluid may flow out of the catheter body 120A and into the patient by way of one or more bearings. The waste fluid (e.g., a portion of the fluid which passes proximally back through the motor from the patient) may flow through the motor assembly 1 at any suitable flow rate, e.g., at a flow rate in a range of 5 mL/hr to 20 mL/hr, or more particularly, in a range of 10 mL/hr to 15 mL/hr. Although described in terms of fluid and waste lines, one will appreciate that the pump and motor be configured to operate without fluid flushing. One purpose of the fluid supply is to cool the motor. In the case of a micromotor dimensioned and configured to be inserted percutaneously, there may not be a need for fluid cooling because the motor heat will be dissipated by the body.
[0059] Access can be provided to a proximal end of the catheter assembly 101 of the catheter pump 100A prior to or during use. In one configuration, the catheter assembly 101 is delivered over a guidewire 235. The guidewire 235 may be conveniently extended through the entire length of the catheter assembly 101 of the catheter pump 100A and out of a proximal end 1455 of the catheter assembly 101. In various embodiments, the connection between the motor assembly 1 and the catheter assembly 101 is configured to be permanent, such that the catheter pump, the motor housing and the motor are disposable components. However, in other implementations, the coupling between the motor housing and the catheter assembly 101 is disengageable, such that the motor and motor housing can be decoupled from the catheter assembly 101 after use. In such embodiments, the catheter assembly 101 distal of the motor can be disposable, and the motor and motor housing can be re-usable.
[0060] In addition,
[0061] In one approach, the guidewire 235 is placed into a peripheral blood vessel, and along the path between that blood vessel and the heart and into a heart chamber, e.g., into the left ventricle. Thereafter, a distal end opening of the catheter pump 100A and guidewire guide tube 20 can be advanced over the proximal end of the guidewire 235 to enable delivery of the catheter pump 100A. After the proximal end of the guidewire 235 is urged proximally within the catheter pump 100A and emerges from the guidewire opening 237 and/or guidewire guide tube 20, the catheter pump 100A can be advanced into the patient. In one method, the guidewire guide tube 20 is withdrawn proximally while holding the catheter pump 100A.
[0062] Alternatively, the clinician can insert the guidewire 235 through the proximal guidewire opening 237 and urge the guidewire 235 along the guidewire guide tube. The clinician can continue urging the guidewire 235 through the patient's vascular system until the distal end of the guidewire 235 is positioned in the desired position, e.g., in a chamber of the patient's heart, a major blood vessel or other source of blood. As shown in
[0063] In yet another embodiment, catheter pump 100A is configured to be inserted using a modified Seldinger technique. The pump may be configured with a lumen therethrough for receiving a guidewire. Unlike the embodiment described above, however, the guidewire is threaded through the pump without a guidewire guide tube. One will appreciate from the description herein that other configurations may be employed for loading the pump onto a guidewire and/or moving the pump to the target location in the body. Examples of similar techniques are described in U.S. Pat. No. 7,022,100 and U.S. Pub. No. 2005/0113631, the entire contents of which patent and publication are incorporated herein for all purposes.
[0064]
[0065] In various embodiments, the rotor 15 and stator assembly 2 are configured as or are components of a frameless-style motor for driving the impeller assembly 116A at the distal end of the pump 100A. For example, the stator assembly 2 can comprise a stator and a plurality of conductive windings producing a controlled magnetic field. The windings can be wrapped about or in a stationary portion 65 of the stator assembly 2. The rotor 15 can comprise a magnetic material, e.g., can include one or more permanent magnets. In some embodiments, the rotor 15 can comprise a multi-pole magnet, e.g., a four-pole or six-pole magnet. Providing changing electrical currents through the windings of the stator assembly 2 can create magnetic fields that interact with the rotor 15 to cause the rotor 15 to rotate. This is commonly referred to as commutation. The console 122 can provide electrical power (e.g., 24V) to the stator assembly 2 to drive the motor assembly 1. One or more leads 9 can electrically communicate with the stator assembly 2, e.g., with one or more Hall sensors used to detect the speed and/or position of the motor. In other embodiments, other sensors (e.g., optical sensors) can be used to measure motor speed. The rotor 15 can be secured to an output shaft 13 (which can comprise a hollow shaft with a central lumen) such that rotation of the rotor 15 causes the output shaft 13 to rotate. In various embodiments, the motor assembly 1 can comprise a direct current (DC) brushless motor. In other embodiments, other types of motors can be used, such as AC motors, gearhead motor, etc. As shown in
[0066]
[0067]
[0068] With continued reference to
[0069] Various components of the motor assembly 1 generate heat. For example, moving parts within the motor assembly 1 (e.g., the rotating output shaft 13 and/or drive shaft 16) can generate heat by virtue of losses through friction, vibrations, and the like, which may increase the overall temperature of the motor assembly 1. Further, heat can be generated by the electrical current flowing through the stator assembly 2 and/or by induction heating caused by conductive components inside a rotating magnetic field. Furthermore, friction between the bearings 18A, 18B and the output shaft 13 and/or friction between the drive shaft 16 and the inner wall of catheter body 120A may also generate undesirable heat in the motor assembly. Inadequate cooling can result in temperature increases of the motor assembly 1, which can present patient discomfort, health risks, or performance losses. This can lead to undesirable usage limitations and engineering complexity, for example, by requiring mitigation for differential heat expansion of adjacent components of different materials. Accordingly, various embodiments disclosed herein can advantageously transfer away generated heat and cool the motor assembly 1 such that the operating temperature of the assembly 1 is sufficiently low to avoid such complexities of use or operation and/or other components of the system. For example, various heat transfer components can be used to move heat away from thermal generation sources and away from the patient. Various aspects of the illustrated device herein are designed to reduce the risk of hot spots, reduce the risk of heat spikes, and/or improve heat dissipation to the environment and away from the patient.
[0070] In some embodiments, the catheter pump makes use of the fluid supply system already embedded in the pump to cool the motor assembly 1 and housing. In some embodiments, heat absorbing capacity of fluid flowing through the flow diverter 3 is used to cool the motor assembly 1. As shown in
[0071] Fluid from the catheter pump 100A can flow proximally through an inner lumen 58 of the catheter body 120A. For example, after initially cooling distal components some or all of the supplied fluid 35 can flow within the drive shaft 16 and/or around the periphery of the drive shaft 16. After initially cooling distal components some or all of the supplied fluid 35 can flow in a space disposed radially between the drive shaft 16 and the catheter body 120A. The proximally-flowing fluid can flow along a flow pathway which removes heat from the motor assembly 1. As shown in
[0072] The embodiment of
[0073]
[0074] Unlike the embodiment of
[0075] The embodiment of
[0076] In the embodiment of
[0077] Moreover, in some embodiments, the console 122 can be configured to change the amount of the third fluid portion 17C flowing along the second fluid pathway before and/or during a treatment procedure to adjust the volume of fluid that is diverted from the inner lumen 58 around the motor assembly 1. For example, the console 122 can send instructions to a pump (such as a peristaltic pump) to adjust the flow rate of fluid shunted or bypassed around the motor assembly 1. In various respects, the terms “shunted” and “bypassed” are used interchangeably herein. In some embodiments, a common pump is applied to all three fluid portions 17A-17C. In other embodiments, one pump is applied to draw the first and second fluid portions 17A, 17B, and a separate pump is applied to draw the third fluid portion 17C.
[0078] In still other embodiments, all or substantially all the fluid flowing proximally through the inner lumen 58 is shunted around the motor assembly 1 along the second fluid pathway. The shunted third fluid portion 17C can be diverted to a waste reservoir and/or to a heat exchanger disposed about the stator assembly 2, as explained above. In such embodiments, all (100%) or substantially all (i.e., between 90% and 100%) of the proximally-flowing fluid does not flow within the motor assembly 1 (e.g., within the flow diverter 3), but is instead diverted around the motor assembly 1. Thus, in some embodiments, there may be no proximally-flowing fluid portions 17A, 17B within the flow diverter 3. In such arrangements, the motor assembly 1 may be adequately cooled without the fluid portions 17A, 17B flowing proximally through the flow diverter 3. The fluid flowing proximally through the inner lumen 58 may also provide sufficient pressure so as to prevent air or other gases from passing distally through the catheter body 120A to the patient.
[0079] Advantageously, the embodiments disclosed in
[0080] Still other thermal management techniques may be suitable in combination with the embodiments disclosed herein. For example, U.S. Patent Publication Nos. 2014/0031606 and 2011/0295345, which are incorporated by reference herein in their entirety and for all purposes, describe structures and materials which may be incorporated in place of or in addition to the devices described above to dissipate heat effectively, as will be understood by one of skill from the description herein. For example, in embodiments in which the motor is miniaturized so as to be disposed within the patient's body, all or substantially all the fluid may bypass or shunt around the motor. In such embodiments, the miniaturized motor may be sufficiently cooled by the flow of blood passing around the motor and/or motor housing.
[0081]
[0082]
[0083] In the illustrated embodiments, the output shaft 13 is permanently coupled with, e.g., laser welded to the drive shaft 16. For example, a welding machine can access the interface 22 by way of the holes 61 formed in the output shaft 13 to weld the output shaft 13 to the drive shaft 16. In other embodiments, the output shaft 13 can be secured to the drive shaft 16 in other ways, e.g., by friction or interference fit, by adhesives, by mechanical fasteners, etc.
[0084] In some embodiments, the motor assembly 1 shown in
[0085] Turning to
[0086] As shown in
[0087] As shown in
[0088] The motor coupling 305 can connect to a distal end portion of the motor output shaft 13, and can connect to a proximal portion of the motor adapter 306. In some arrangements, the motor coupling 305 can comprise a first opening 311A sized and shaped to receive the proximal portion of the motor adapter 306 therein, and a second opening 311B sized and shaped to receive the distal end portion of the motor output shaft 13. In various embodiments, at least one of the openings 311A, 311B can comprise a polygonal opening, e.g., a rectangular or square opening with at least one flat surface or edge. In the illustrated embodiment, the first opening 311A can comprise a polygonal opening, and the second opening 311B can comprise a rounded opening. In other embodiments, the first opening 311A can comprise a rounded opening, and the second opening 311B can comprise a polygonal opening. In
[0089] As explained above, fluids (such as saline) can flow proximally through the catheter pump system during operation of the impeller. For example, as shown in
[0090] In various embodiments, it can be advantageous to prevent or impede fluids from entering the motor 300 and damaging or destroying sensitive components within the motor 300. Accordingly, in the illustrated embodiment, the seal 303 and the gasket 304 can be disposed in the chamber of the flow diverter 3 to prevent or impede fluids from damaging sensitive components of the motor. In some embodiments, some or all of the fluid conveyed along the returning fluid pathway 317 exits the flow diverter 3 by way of a first return pathway 317A. For example, the first return pathway 317A can be in fluid communication with a waste line to convey fluid flowing therein to and along the waste line (such as waste line 7 described above) to a reservoir. The first return pathway 317A may comprise a conduit that directs a portion of the fluid to bypass the motor assembly 1.
[0091] In some embodiments, some of the returning fluid (a second fluid pathway 317B) can pass within the lumen 355 of the motor output shaft 13. For example, in such embodiments, the returning fluid 317 can flow through the inner lumen 358 of the catheter body 120A, which can fluidly communicate with the lumen 355 of the motor output shaft 13. Fluid conveyed in the returning fluid pathway 317 can flow proximally within and/or around the drive shaft 16 (which can be disposed inside the inner lumen 358 of the catheter body 120A), through the motor adapter 306, the motor coupler 305, the seal 303, and the proximal flow diverter portion 3B, and into the lumen 355 of the motor output shaft 13. In other embodiments, no or little fluid may flow through the lumen 355 of the output shaft 13.
[0092] As shown in
[0093] As explained herein, a guidewire guide tube (not shown in
[0094]
[0095] As shown in
[0096] In addition, in some embodiments, it can be advantageous to electrically separate or isolate the shaft assembly from the patient, for example, to reduce the risk of electrical shock from the motor. In such embodiments, an insulating coating can be provided over part or all of the shaft assembly 302 to electrically insulate the shaft assembly 302. For example, in some embodiments, a shaft assembly including the output shaft 13 can be coated in an insulating material. In some embodiments, a shaft assembly including the drive shaft 16 can be coated in an insulating material. In some embodiments, a shaft assembly including the drive shaft 16 and the output shaft 13 can be coated in an insulating material. The insulating material which coats the shaft assembly 302 can comprise any suitable insulator, such as polyimide.
[0097]
[0098]
[0099] Unlike the embodiments of
Example 1
[0100] In some embodiments, an adjunct device, which may be referred to herein as a “nanosphere lubrication injection applicator,” or “NLIA” (not shown), may be included in catheter pump 100A, such as, for example, to facilitate purging one or more portions of catheter pump 100A during operation and to ensure that blood, debris, and/or other fluids and/or unwanted matter do not accumulate within catheter pump 100A during operation to an extent that inhibits or otherwise interrupts operation of catheter pump 100A. In some embodiments, the NLIA may include a reservoir or chamber (e.g., a “lubrication relief chamber” or “dispensary”) that stores any of a variety of particles or substances capable of being injected into or otherwise supplied to catheter pump 100A during operation of pump 100A.
[0101] In some embodiments, the particles stored by the dispensary may include nanosphere particles, such as particles having a diameter on the scale of nanometers. In some embodiments, the particles are larger or smaller than nanospheres, such as on the order of micrometers, and the like. In some embodiments, nanosphere particles may have a diameter in the range of 5 nanometers to 100 nanometers (or about 0.1 micron). The composition of each nanosphere particle may vary according to a variety of desired particle characteristics, such as for example, thrombogenicity, anticoagulation properties, anti-foaming properties, hydrophilic properties, and the like. Accordingly, in some example embodiments, the nanosphere particles may include, but are not limited to, beaded oils, mineral oils, synthetic hydrocarbons, lubricants, such as copper (Cu), copper oxide (CuO), Iron (Fe), Nickel (Ni), Titanium Dioxide (TiO.sub.2), and the like.
[0102] In various embodiments, the NLIA may be positioned near and/or fluidly coupled with flow diverter 3, such as for example, as an adjunct component to flower diverter 3. For example, in some embodiments, the NLIA may include a reservoir of beaded nanosphere particles that is maintained in fluid communication with any cavity of catheter pump 100A, such as any portion of flow diverter 3, including, but not limited to, any of distal chamber 5, rotor chamber 4, and/or proximal chamber 10. Likewise, in some embodiments, the NLIA may be in fluid communication with any other lumen or flow channel of catheter pump 100A, such as lumen 55 of output shaft 13, lumen 58 of catheter body 120A, and the like. Accordingly, it will be appreciated that nanosphere particles may be provided to any portion of catheter pump 100A, as described herein, such as for example, to support a variety of fluid flow characteristics and properties within catheter pump 100A, including thrombogenicity, hydrophilicity, anti-clotting or clot reduction, anti-coagulation or coagulation reduction, lubrication, cooling, and the like.
[0103] In some embodiments, a pressure sensor (not shown) may be operably coupled to a control valve of the NLIA, such as a valve disposed between the NLIA and a portion of catheter pump 100A (e.g., flow diverter 3). The pressure sensor may detect a condition of catheter pump 100A (e.g., an increase in fluid pressure, a decrease in fluid pressure, and the like), and in response to detecting the change in fluid pressure, the pressure sensor may control (e.g., in conjunction with a computer processor and/or control circuit), the valve between the NLIA and flow diverter 3 to open, such that nanosphere particles may be supplied from the NLIA to flow diverter 3. In some embodiments, other types of sensors may be implemented, such as velocity sensors, flow meters, and the like. For example, a velocity sensor or flow meter may detect a reduction in fluid velocity or flow rate (signifying a clog or occlusion of some portion of catheter pump 100A), and in response, the valve between the NLIA and flow diverter 3 may be opened to release nanosphere particles into catheter pump 100A, which may act to dissolve or otherwise ameliorate the blood clot, debris, and the like responsible for the flow reduction.
Example 2
[0104] In some embodiments, a semi-durable coating (e.g., a thin film) having a time-release matrix of nanosphere particles, as described herein, may be applied to any surface of catheter pump 100A. For example, in some embodiments, the nanosphere coating may include lubricant nanospheres, anticoagulant nanospheres, anti-foaming nanospheres, hydrophilic nanospheres, thrombin inhibitors (e.g., bivalirudin, argatroban, and the like) and/or any combination of these. Similarly, in various embodiments, coatings may include, but are not limited to, for example, phosphorylcholine (PC) coatings, phospholipid coatings, poly (2-methoxyethyl-acrylate) (PMEA) coatings, polyethylene oxide (PEO) coatings, silicone coatings, polymeric coatings, such as polymeric coatings with variable release rates for impregnated compounds, polymeric coatings incorporating polycaprolactone (PCL)-polysiloxane-PCL triblock copolymers, polyvinylchloride (PVC) coatings, and the like.
[0105] In some embodiments, more than one layer may be coated on surfaces of catheter pump 100A. For example, in some embodiments, one or more layers of lubricant nanospheres, anticoagulant and/or heparin filled nanospheres, such as nanospheres encapsulating a PEG glycol dispersion, may be applied to surfaces of catheter pump 100A. In addition, in at least some implementations, coatings may be applied using any of a variety of suitable methods, such as for example, but not limited to, application of thin films, direct fluid injection, air atomized spraying, and the like.
[0106] Moreover, although any desired surface of catheter pump 100A may be coated, in at least some embodiments, example surfaces that may be coated include seals, thrust bearings, journal bearings, ball bearings, corners and other angled surfaces, “dead” spaces in which fluid flow may tend to stagnate or pool, and the like. In at least some embodiments, nanosphere particles may be released from the coating in which they are impregnated over time, such as part of a time-release formulation or time-release composition, to facilitate long lasting anti-thrombogenicity, anticoagulation, anti-foaming, hydrophilicity, and/or other desired properties, as described herein.
Example 3
[0107] With reference to
[0108] Similarly, in some embodiments, a third portion 1006 and/or a fourth portion 1008 may be smoothed to reduce or eliminate one or more angled surfaces associated therewith that may impede or otherwise interfere with fluid flow, such as fluid flowing proximally within lumen 58 (and/or transitioning from lumen 57 into lumen 58) of catheter body 120A. Likewise, a fifth portion 1010 and/or a sixth portion 1012 may be smoothed to reduce or eliminate one or more angled surfaces associated therewith that may impede or otherwise interfere with fluid flow, such as fluid flowing proximally within lumen 58 of catheter body 120A. In general terms, in at least some embodiments, lumen 58 may exclude angles, sharp turns, corners, and the like, such that lumen 58 includes a substantially smooth interior surface to facilitate fluid flow therein.
[0109] In addition, in at least some embodiments, and as shown with reference to
[0110] Accordingly, in some embodiments, one or more regions or portions, such as regions 1104, 1106, 1108, 1110, and/or 1112 may be smoothed and/or reshaped to reduce or eliminate one or more angled surfaces associated therewith that may otherwise impede or otherwise interfere with fluid flow. For example, as shown, a geometry of one or more regions 1104-1112 may be adjusted to minimize, reduce, or eliminate right angles, perpendicular entry channels, fluid pockets, abrupt transitions and angles, and other obstacles to fluid flow. In some embodiments, right angles and the like may be reduced by adding “steps” or one or more series of perpendicular geometries. Likewise, sloping geometries and other similar shapes may be implemented to avoid abrupt and other similar geometric features that disrupt flow, induce turbulent flow, and the like.
[0111] In some embodiments, one or more gaps or spaces within catheter pump 100A may also be reduced or eliminated, such as by adding fillers, expandable lips or other expanding and/or space occluding or space filling features, and the like, to prevent large thrombus and/or particulate build-up. For example, a gap between an inner sheath and an outer sheath (e.g., a gap between catheter body 120A and drive shaft 16) may be reduced, such as by forming catheter pump 100A to include a smaller gap, adding a component, such as a lip, a baffle, a railing, or another strip of material to reduce the gap, and the like. Likewise, other gaps, lumen diameters, and the like may be variously reduced to prevent large thrombus build-up. In some implementations, a variety of baffles, railings, sloped surfaces, conical and pyramidal surfaces (as described herein), and other similar shapes may be added within catheter pump 100A to eliminate or minimize fluid pockets and other areas that tend to encourage clotting, such as those where fluid may experience turbulent flow, build-up, stagnation or pooling, and the like.
[0112] In addition, in at least some embodiments, as shown with reference to
Example 4
[0113] In some embodiments, catheter pump 100A may be purged or flushed using a fluid (or “clearing fluid”), which may be supplied to catheter pump 100A to clean and/or flush one or more portions of catheter pump 100A during operation. In some embodiments, the clearing fluid may include any suitable fluid, such as any solvent fluid that dissolves blood clots and/or other material or debris. Likewise, the clearing fluid may simply include saline, water, and/or another such fluid. In some embodiments, the clearing fluid may include one or more medicaments, such as heparin. For example, in at least one embodiment, the clearing fluid is heparinized-saline. In some embodiments, the clearing fluid may also include one or more lubricants, such as any lubricant and/or nanosphere particle described herein. More generally, it will be appreciated that the clearing fluid may be any fluid suitable for clearing blood, blood clots, and/or other debris from catheter pump 100A during operation (e.g., fluids that are also safe for placement in a human body).
[0114] In some embodiments, clearing fluid may be delivered via a purge line (not shown), which may be fluidly coupled to catheter pump 100A in any suitable location. For example, a purge line may be coupled to any portion of catheter body 120A, such as to lumen 57 and/or lumen 58 (e.g., for clearing distally flowing and/or proximally flowing portions of catheter body 120A). Likewise, the purge line may be fluidly coupled to motor 1, such as to flow diverter 3 and/or one or more of distal chamber 5, proximal chamber 10, and/or rotor chamber 4. In addition, the purge line may, in some embodiments, be fluidly coupled to any other portion of catheter pump 100A. In some embodiments, more than one purge line may be fluidly coupled to catheter pump 100A, such as to supply clearing fluid to one or more portions of catheter pump 100A.
[0115] In some embodiments, a sensor, such as pressure sensor, (not shown) may be operably coupled to a valve disposed between purge line and a portion of catheter pump 100A (e.g., flow diverter 3). The pressure sensor may detect a condition of catheter pump 100A (e.g., an increase in fluid pressure, a decrease in fluid pressure, and the like), and in response to detecting the change in fluid pressure, the pressure sensor may control (e.g., in conjunction with a computer processor and/or control circuit), the valve between the purge line and catheter pump 100A to open, such that clearing fluid may be supplied to catheter pump 100A. In some embodiments, other types of sensors may be implemented, such as velocity sensors, flow meters, and the like. For example, a velocity sensor or flow meter may detect a reduction in fluid velocity or flow rate (signifying a clog or occlusion of some portion of catheter pump 100A), and in response, the valve may be opened to release clearing fluid into catheter pump 100A, which may act to dissolve or otherwise ameliorate the blood clot, debris, and the like responsible for the flow reduction.
Example 5
[0116] With reference to
[0117] Accordingly, with reference to
[0118] To facilitate vertical priming, in at least some embodiments, an inflow valve or inflow port 1306 may be included in catheter pump 100A, such as for example, in fluid communication with a proximal portion of catheter pump 100A, such as proximal chamber 10 and/or a proximal portion of impeller assembly 116A (e.g., depending upon the portion of catheter pump 100A being primed and/or one or more other factors). A relief valve 1308 may also be provided distally of inflow port 1306. In the example embodiment, relief valve 1308 may allow air to exit catheter pump 100A as the device is filled with fluid 35 from inflow port 1306 toward relief valve 1308.
[0119] In some embodiments, a relief chamber 1310 may also be included in fluid communication with relief valve 1308 to facilitate removal of air and/or fluid 35 if catheter pump 100A is overfilled. In some embodiments, one or more sensors may also be included, such as to monitor a priming status of catheter pump 100A, to activate filling or priming in response to determining that catheter pump 100A requires additional fluid 35, to activate relief valve 1308 in response to an increase in pressure near relief valve 1308, and the like.
[0120] Although the embodiments disclosed herein have been described with reference to particular embodiments, it is to be understood that these embodiments are merely illustrative of the principles and applications of the present inventions. It is therefore to be understood that numerous modifications can be made to the illustrative embodiments and that other arrangements can be devised without departing from the spirit and scope of the present inventions as defined by the appended claims. Thus, it is intended that the present application cover the modifications and variations of these embodiments and their equivalents.